| Dr Laurel Corea, DPT | |
|
430 Sills Road, Yaphank, NY 11980-1198 | |
| (631) 924-5583 | |
| Not Available |
| Full Name | Dr Laurel Corea |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 4 Years |
| Location | 430 Sills Road, Yaphank, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609467521 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 046664 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ati Holdings Llc | 9537112719 | 375 |
News Archive
New data released today show that enrollment at U.S. medical schools is on target to reach an increase of 30 percent by 2016, according to the annual Medical School Enrollment Survey conducted by the AAMC (Association of American Medical Colleges) Center for Workforce Studies.
Heart disease has topped mortality charts as the No. 1 killer of men and women for many decades, but a novel analysis of American literary fiction by two physicians finds the disorder's presence in great novels has remained relatively modest.
From Thanksgiving to New Year's, there are many wishes for everyone to have a blissful and celebratory holiday season. But for many people, the holidays bring more misery than mirth, particularly at a time when the ailing economy can't seem to recover quickly enough and money worries remain on people's minds.
Repros Therapeutics Inc. today announced financial results for the third quarter ended September 30, 2010 and provided an update on corporate actions.
GlaxoSmithKline today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling for its respiratory products Serevent and Advair. The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of asthma, including salmeterol, the active ingredient in Serevent and one of the active ingredients in Advair.
› Verified 5 days ago
| Provider Name | Ati Holdings Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396781050 PECOS PAC ID: 9537112719 Enrollment ID: O20061020000349 |
News Archive
New data released today show that enrollment at U.S. medical schools is on target to reach an increase of 30 percent by 2016, according to the annual Medical School Enrollment Survey conducted by the AAMC (Association of American Medical Colleges) Center for Workforce Studies.
Heart disease has topped mortality charts as the No. 1 killer of men and women for many decades, but a novel analysis of American literary fiction by two physicians finds the disorder's presence in great novels has remained relatively modest.
From Thanksgiving to New Year's, there are many wishes for everyone to have a blissful and celebratory holiday season. But for many people, the holidays bring more misery than mirth, particularly at a time when the ailing economy can't seem to recover quickly enough and money worries remain on people's minds.
Repros Therapeutics Inc. today announced financial results for the third quarter ended September 30, 2010 and provided an update on corporate actions.
GlaxoSmithKline today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling for its respiratory products Serevent and Advair. The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of asthma, including salmeterol, the active ingredient in Serevent and one of the active ingredients in Advair.
› Verified 5 days ago
| Provider Name | Ati Holdings Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1396781050 PECOS PAC ID: 9537112719 Enrollment ID: O20061023000321 |
News Archive
New data released today show that enrollment at U.S. medical schools is on target to reach an increase of 30 percent by 2016, according to the annual Medical School Enrollment Survey conducted by the AAMC (Association of American Medical Colleges) Center for Workforce Studies.
Heart disease has topped mortality charts as the No. 1 killer of men and women for many decades, but a novel analysis of American literary fiction by two physicians finds the disorder's presence in great novels has remained relatively modest.
From Thanksgiving to New Year's, there are many wishes for everyone to have a blissful and celebratory holiday season. But for many people, the holidays bring more misery than mirth, particularly at a time when the ailing economy can't seem to recover quickly enough and money worries remain on people's minds.
Repros Therapeutics Inc. today announced financial results for the third quarter ended September 30, 2010 and provided an update on corporate actions.
GlaxoSmithKline today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling for its respiratory products Serevent and Advair. The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of asthma, including salmeterol, the active ingredient in Serevent and one of the active ingredients in Advair.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laurel Corea, DPT 26 Thorne St, Ronkonkoma, NY 11779-4230 Ph: (631) 375-9655 | Dr Laurel Corea, DPT 430 Sills Road, Yaphank, NY 11980-1198 Ph: (631) 924-5583 |
News Archive
New data released today show that enrollment at U.S. medical schools is on target to reach an increase of 30 percent by 2016, according to the annual Medical School Enrollment Survey conducted by the AAMC (Association of American Medical Colleges) Center for Workforce Studies.
Heart disease has topped mortality charts as the No. 1 killer of men and women for many decades, but a novel analysis of American literary fiction by two physicians finds the disorder's presence in great novels has remained relatively modest.
From Thanksgiving to New Year's, there are many wishes for everyone to have a blissful and celebratory holiday season. But for many people, the holidays bring more misery than mirth, particularly at a time when the ailing economy can't seem to recover quickly enough and money worries remain on people's minds.
Repros Therapeutics Inc. today announced financial results for the third quarter ended September 30, 2010 and provided an update on corporate actions.
GlaxoSmithKline today announced that it has received a letter from the U.S. Food and Drug Administration directing revisions to product labeling for its respiratory products Serevent and Advair. The letter concludes discussions between GSK and the agency following FDA advisory committee meetings regarding the safety profile of long-acting beta2-agonists in the treatment of asthma, including salmeterol, the active ingredient in Serevent and one of the active ingredients in Advair.
› Verified 5 days ago
Mrs. Shreya Dhakal, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 35 Bergers Ct E, Yaphank, NY 11980 Phone: 631-891-9937 | |
Therapy House Calls Pt Pc Physical Therapist Medicare: Medicare Enrolled Practice Location: 35 Bergers Ct E, Yaphank, NY 11980 Phone: 631-891-9937 | |
Raj Devalla, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 35 Bergers Ct E, Yaphank, NY 11980 Phone: 631-891-9936 | |
Russell J Warren, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 472 Yaphank Middle Island Rd, Yaphank, NY 11980 Phone: 631-775-7693 | |
Mr. Bryan Scott Knoell, MS,PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 22 Jefferson Commons, Yaphank, NY 11980 Phone: 631-775-0408 Fax: 631-775-0408 |